What is the treatment for anaphylactic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Anaphylactic Shock

Immediately administer intramuscular epinephrine 0.3-0.5 mg (1:1000 concentration) into the anterolateral thigh as the first-line, life-saving treatment for anaphylactic shock. 1, 2, 3, 4

Immediate First-Line Treatment

Epinephrine Administration (Primary Treatment)

  • Administer IM epinephrine 0.3-0.5 mg (1:1000 concentration) for adults or 0.01 mg/kg for children into the anterolateral thigh immediately upon recognition of anaphylaxis 1, 3, 4
  • Repeat the dose every 5-15 minutes as needed if symptoms persist or recur 2, 3
  • Between 7-18% of patients require more than one dose of epinephrine 1
  • Epinephrine is the only medication with life-saving effects across multiple organ systems, preventing and relieving airway obstruction and shock 5

Patient Positioning and Oxygen

  • Position the patient supine with legs elevated (unless respiratory distress prevents this position) 3
  • Provide supplemental oxygen and monitor oxygen saturation continuously 3

Activate Emergency Response

  • Call emergency medical services (EMS) immediately, even if epinephrine is administered 1
  • Approximately 500-1000 people die annually in the United States from anaphylaxis, and patients may require advanced interventions including intubation, IV fluids, and vasopressors 1

Advanced Treatment for Severe or Refractory Cases

IV Epinephrine (When IM Fails or Shock is Profound)

  • If IV access is already established and the patient has profound hypotension unresponsive to IM epinephrine and IV fluids, administer IV epinephrine 0.05-0.1 mg (1:10,000 concentration) slowly over several minutes 2, 3
  • This represents only 5-10% of the cardiac arrest dose to minimize adverse cardiovascular effects 2
  • For persistent hypotension, initiate continuous epinephrine infusion at 5-15 μg/min 2, 3
  • Continuous hemodynamic monitoring is mandatory when administering IV epinephrine 2

Fluid Resuscitation

  • Establish IV access and administer crystalloid bolus: 500-1000 mL for adults or 20 mL/kg for children 3
  • Anaphylactic shock can cause up to 37% reduction in circulating blood volume due to vasodilation and increased capillary permeability 6

Persistent Bronchospasm

  • If bronchospasm is unresponsive to epinephrine, administer albuterol nebulization 2.5-5 mg in 3 mL saline 3

Adjunctive (Second-Line) Treatments

These medications do NOT substitute for epinephrine and should never delay its administration 7

Antihistamines

  • H1 antagonist: Diphenhydramine 25-50 mg IV/IM (1-2 mg/kg for children) 3
  • H2 antagonist: Ranitidine 50 mg IV for adults (1 mg/kg for children) 3

Corticosteroids (To Prevent Biphasic Reactions)

  • Methylprednisolone 1-2 mg/kg/day IV or prednisone 0.5 mg/kg orally 3
  • These provide no acute benefit but may prevent late-phase reactions 3

Special Clinical Situations

Patients on Beta-Blockers

  • If the patient is unresponsive to epinephrine and takes beta-blockers, administer glucagon 1-5 mg IV (20-30 μg/kg for children, maximum 1 mg) over 5 minutes, followed by infusion of 5-15 μg/min 2, 3
  • Beta-blockade can prevent epinephrine's therapeutic effects 2

Cardiac Arrest from Anaphylaxis

  • Perform standard CPR and advanced life support 3
  • Administer high-dose epinephrine IV: 1-3 mg (1:10,000) slowly over 3 minutes, followed by 3-5 mg over 3 minutes, then infusion of 4-10 μg/min 3

Refractory Hypotension

  • Consider alternative vasopressors such as dopamine (2-20 μg/kg/min) if hypotension persists despite epinephrine 2
  • Vasopressin has been reported successful in case reports of severe anaphylactic shock refractory to epinephrine 8

Monitoring and Observation

  • Monitor vital signs continuously (blood pressure, heart rate, respiratory rate, oxygen saturation) 3
  • Observe for at least 6 hours or until stable and symptoms have resolved 3
  • The observation period should be individualized as biphasic reactions are unpredictable and can occur outside typical observation windows 3, 9

Critical Pitfalls to Avoid

  • Never delay epinephrine administration while focusing on antihistamines or corticosteroids 2, 7
  • Do not confuse epinephrine concentrations: use 1:1000 (1 mg/mL) for IM and 1:10,000 (0.1 mg/mL) for IV 2
  • Avoid administering IV epinephrine too rapidly, which increases risk of tachyarrhythmias, hypertension, and potentially lethal arrhythmias 2
  • Do not use vasodilators (such as isosorbide) which will worsen the hypotension 6
  • Recognize that early intubation may be necessary for airway obstruction—do not delay if edema is progressing 6, 9

Discharge Planning

  • Prescribe an epinephrine autoinjector and provide thorough education on its use 3
  • Identify and document the triggering antigen 10
  • Provide avoidance instructions and consider allergy/immunology referral 10

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

IV Epinephrine Dosing in Anaphylactic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Guideline

Anafilaxia y Choque Anafiláctico

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anaphylactic shock: pathophysiology, recognition, and treatment.

Seminars in respiratory and critical care medicine, 2004

Research

Successful treatment of severe anaphylactic shock with vasopressin. Two case reports.

International archives of allergy and immunology, 2004

Research

Anaphylaxis: Emergency Department Treatment.

Emergency medicine clinics of North America, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.